Abstract
Trazodone, a triazolopyridine antidepressant, is commonly used in the treatment of depression and insomnia. Kv4.3 channels are transiently, and rapidly, inactivating Kv channels that are highly expressed in cardiac myocytes and neurons. To determine the electrophysiological basis for the cardiac and neuronal actions of trazodone, we studied the effects of trazodone on Kv4.3 currents stably expressed in Chinese hamster ovary cells using the whole-cell patch-clamp technique. Trazodone decreased the peak amplitude of Kv4.3 in a concentration-dependent manner with an IC50 of 55.4 μM. Under control conditions, the time course of inactivation of Kv4.3 at +40 mV was fitted to a double exponential function. Trazodone produced a concentration-dependent slowing of the fast and slow components of Kv4.3 inactivation during a voltage step to +40 mV. The inhibition of Kv4.3 by trazodone was voltage independent over the entire voltage range tested. Trazodone shifted the voltage dependence of the steady-state inactivation of Kv4.3 to a hyperpolarizing direction. However, the slope factor of the steady-state inactivation was not affected by trazodone. Under control conditions, the closed-state inactivation of Kv4.3 was fitted to a single exponential function. Trazodone significantly accelerated the closed-state inactivation of Kv4.3. Trazodone produced a weak use-dependent inhibition of Kv4.3 at frequencies of 1 and 2 Hz. m-Chlorophenylpiperazine (m-CPP), a major metabolite of trazodone, inhibited Kv4.3 less potently than trazodone, with an IC50 of 118.6 μM. These results suggest that trazodone preferentially inhibited Kv4.3 by both binding to the closed state and accelerating the closed-state inactivation of the channel.
Similar content being viewed by others
References
Ahn HS, Choi JS, Choi BH, Kim MJ, Rhie DJ, Yoon SH, Jo YH, Kim MS, Sung KW, Hahn SJ (2005) Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole. Neuroscience 133:1007–1019
Alvarez W Jr, Pickworth KK (2003) Safety of antidepressant drugs in the patient with cardiac disease: a review of the literature. Pharmacotherapy 23:754–771
Anderson MP, Mochizuki T, Xie J, Fischler W, Manger JP, Talley EM, Scammell TE, Tonegawa S (2005) Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. Proc Natl Acad Sci U S A 102:1743–1748
Astori S, Wimmer RD, Prosser HM, Corti C, Corsi M, Liaudet N, Volterra A, Franken P, Adelman JP, Luthi A (2011) The CaV3.3 calcium channel is the major sleep spindle pacemaker in thalamus. Proc Natl Acad Sci USA 108:13823–13828
Bett GC, Morales MJ, Strauss HC, Rasmusson RL (2006) KChIP2b modulates the affinity and use-dependent block of Kv4.3 by nifedipine. Biochem Biophys Res Commun 340:1167–1177
Caccia S, Ballabio M, Fanelli R, Guiso G, Zanini MG (1981) Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine, by gas–liquid chromatography. J Chromatogr 210:311–318
Casis O, Sanchez-Chapula JA (1998a) Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel. J Cardiovasc Pharmacol 32:521–526
Casis O, Sanchez-Chapula JA (1998b) Mechanism of block of cardiac transient outward K+ current I(to) by antidepressant drugs. J Cardiovasc Pharmacol 32:527–534
Choi BH, Choi JS, Min DS, Yoon SH, Rhie DJ, Jo YH, Kim MS, Hahn SJ (2001) Effects of (−)-epigallocatechin-3-gallate, the main component of green tea, on the cloned rat brain Kv1.5 potassium channels. Biochem Pharmacol 62:527–535
Choi JJ, Huang GJ, Shafik E, Wu WH, McArdle JJ (1992) Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins. J Pharmacol Exp Ther 263:49–53
Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1–6
Crunelli V, Cope DW, Hughes SW (2006) Thalamic T-type Ca2+ channels and NREM sleep. Cell Calcium 40:175–190
DeVane CL, Boulton DW, Miller LF, Miller RL (1999) Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats. Int J Neuropsychopharmacol 2:17–23
Dixon JE, Shi W, Wang HS, McDonald C, Yu H, Wymore RS, Cohen IS, McKinnon D (1996) Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res 79:659–668
Elsherbiny ME, El-Kadi AO, Brocks DR (2008) The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. J Pharm Pharm Sci 11:147–159
Fabre LF (1990) Trazodone dosing regimen: experience with single daily administration. J Clin Psychiatry 51(Suppl):23–26
Fernandez A, Bang SE, Srivathsan K, Vieweg WV (2007) Cardiovascular side effects of newer antidepressants. Anadolu Kardiyol Derg 7:305–309
Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S, Demolombe S (2007) Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol 582:675–693
Glassman AH, Pardell R, Woodring S (1988) Cardiovascular effects of the standard tricyclic antidepressants. Clin Chem 34:856–858
Hahn SJ, Choi JS, Rhie DJ, Oh CS, Jo YH, Kim MS (1999) Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells. Eur J Pharmacol 367:113–118
Hayes PE, Kristoff CA (1986) Adverse reactions to five new antidepressants. Clin Pharm 5:471–480
Janowsky D, Curtis G, Zisook S, Kuhn K, Resovsky K, Le Winter M (1983) Trazodone-aggravated ventricular arrhythmias. J Clin Psychopharmacol 3:372–376
Jeong I, Choi BH, Hahn SJ (2011) Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation. Br J Pharmacol 163:510–520
Jerng HH, Pfaffinger PJ, Covarrubias M (2004) Molecular physiology and modulation of somatodendritic A-type potassium channels. Mol Cell Neurosci 27:343–369
Jo SH, Youm JB, Lee CO, Earm YE, Ho WK (2000) Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline. Br J Pharmacol 129:1474–1480
Kanyshkova T, Broicher T, Meuth SG, Pape HC, Budde T (2011) A-type K+ currents in intralaminar thalamocortical relay neurons. Pflugers Arch 461:545–556
Kaynak H, Kaynak D, Gozukirmizi E, Guilleminault C (2004) The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med 5:15–20
Kim HJ, Ahn HS, Choi JS, Choi BH, Hahn SJ (2011) Effects of ranolazine on cloned cardiac Kv4.3 potassium channels. J Pharmacol Exp Ther 339:952–958
Kirsch GE, Yeh JZ, Oxford GS (1986) Modulation of aminopyridine block of potassium currents in squid axon. Biophys J 50:637–644
Kraus RL, Li Y, Jovanovska A, Renger JJ (2007) Trazodone inhibits T-type calcium channels. Neuropharmacology 53:308–317
Lee HM, Hahn SJ, Choi BH (2010) Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin 31:429–435
Levenson JL (1999) Prolonged QT interval after trazodone overdose. Am J Psychiatry 156:969–970
Maes M, Westenberg H, Vandoolaeghe E, Demedts P, Wauters A, Neels H, Meltzer HY (1997) Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine. J Clin Psychopharmacol 17:358–364
Mazur A, Strasberg B, Kusniec J, Sclarovsky S (1995) QT prolongation and polymorphous ventricular tachycardia associated with trasodone–amiodarone combination. Int J Cardiol 52:27–29
McCormick DA, Bal T (1997) Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 20:185–215
Mendelson WB (2005) A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 66:469–476
Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M (1994) Trazodone for antidepressant-associated insomnia. Am J Psychiatry 151:1069–1072
Ohya S, Tanaka M, Oku T, Asai Y, Watanabe M, Giles WR, Imaizumi Y (1997) Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel α-subunit, Kv4.3 in the rat. FEBS Lett 420:47–53
Pacher P, Kecskemeti V (2004) Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des 10:2463–2475
Pahapill PA, Schlichter LC (1990) Modulation of potassium channels in human T lymphocytes: effects of temperature. J Physiol 422:103–126
Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C 3rd (1998) Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther 284:208–214
Park KS, Kong ID, Park KC, Lee JW (1999) Fluoxetine inhibits L-type Ca2+ and transient outward K+ currents in rat ventricular myocytes. Yonsei Med J 40:144–151
Perchenet L, Hilfiger L, Mizrahi J, Clement-Chomienne O (2001) Effects of anorexinogen agents on cloned voltage-gated K+ channel hKv1.5. J Pharmacol Exp Ther 298:1108–1119
Ravens U, Wettwer E (2011) Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovasc Res 89:776–785
Rotzinger S, Fang J, Baker GB (1998) Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab Dispos 26:572–575
Sah R, Ramirez RJ, Oudit GY, Gidrewicz D, Trivieri MG, Zobel C, Backx PH (2003) Regulation of cardiac excitation–contraction coupling by action potential repolarization: role of the transient outward potassium current (I to). J Physiol 546:5–18
Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the I Kr potassium channel. Cell 81:299–307
Serodio P, Rudy B (1998) Differential expression of Kv4 K+ channel subunits mediating subthreshold transient K+ (A-type) currents in rat brain. J Neurophysiol 79:1081–1091
Serodio P, Vega-Saenz de Miera E, Rudy B (1996) Cloning of a novel component of A-type K+ channels operating at subthreshold potentials with unique expression in heart and brain. J Neurophysiol 75:2174–2179
Song JH, Ham SS, Shin YK, Lee CS (2000) Amitriptyline modulation of Na+ channels in rat dorsal root ganglion neurons. Eur J Pharmacol 401:297–305
Sung MJ, Ahn HS, Hahn SJ, Choi BH (2008) Open channel block of Kv3.1 currents by fluoxetine. J Pharmacol Sci 106:38–45
Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E (2004) Pharmacology of cardiac potassium channels. Cardiovasc Res 62:9–33
Tarantino P, Appleton N, Lansdell K (2005) Effect of trazodone on hERG channel current and QT-interval. Eur J Pharmacol 510:75–85
Teschemacher AG, Seward EP, Hancox JC, Witchel HJ (1999) Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol 128:479–485
Traboulsie A, Chemin J, Kupfer E, Nargeot J, Lory P (2006) T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol Pharmacol 69:1963–1968
Tsaur ML, Chou CC, Shih YH, Wang HL (1997) Cloning, expression and CNS distribution of Kv4.3, an A-type K+ channel alpha subunit. FEBS Lett 400:215–220
Vatassery GT, Holden LA, Hazel DK, Dysken MW (1997) Determination of trazodone and its metabolite, 1-m-chlorophenyl-piperazine, in human plasma and red blood cell samples by HPLC. Clin Biochem 30:149–153
Vincent GM (2001) Prevention of drug-induced long QT syndrome: gender, chemistry, and education. J Cardiovasc Electrophysiol 12:546–547
Vitullo RN, Wharton JM, Allen NB, Pritchett EL (1990) Trazodone-related exercise-induced nonsustained ventricular tachycardia. Chest 98:247–248
Wang S, Bondarenko VE, Qu YJ, Bett GC, Morales MJ, Rasmusson RL, Strauss HC (2005) Time- and voltage-dependent components of Kv4.3 inactivation. Biophys J 89:3026–3041
Wooltorton JR, Mathie A (1995) Potent block of potassium currents in rat isolated sympathetic neurones by the uncharged form of amitriptyline and related tricyclic compounds. Br J Pharmacol 116:2191–2200
Yeh JZ, Oxford GS, Wu CH, Narahashi T (1976) Dynamics of aminopyridine block of potassium channels in squid axon membrane. J Gen Physiol 68:519–535
Zitron E, Kiesecker C, Scholz E, Luck S, Bloehs R, Kathofer S, Thomas D, Kiehn J, Kreye VA, Katus HA, Schoels W, Karle CA (2004) Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Naunyn Schmiedebergs Arch Pharmacol 370:146–156
Acknowledgments
We thank Dr. Imaizumi (Department of Molecular and Cellular Pharmacology, Nagoya City University, Japan) for the Kv4.3 cDNA. This work was supported by a grant from the Medical Research Center, Korea Science and Engineering Foundation, Republic of Korea (R13-2002-005-01002-0).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chae, Y.J., Choi, JS. & Hahn, S.J. Inhibition of Kv4.3 potassium channels by trazodone. Naunyn-Schmiedeberg's Arch Pharmacol 386, 711–719 (2013). https://doi.org/10.1007/s00210-013-0870-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-013-0870-3